Table 1 Clinical features of symptomatic and asymptomatic COVID-19 patients
From: Atypical presentations of coronavirus disease 2019 (COVID-19) from onset to readmission
Features | Symptomatic (n=69) | Asymptomatic (n=10) | P-value |
|---|---|---|---|
Sex | 0.962a | ||
Male# | 38(55.1%) | 6(60.0%) | |
Female# | 31(44.9%) | 4(40.0%) | |
Age | 42.2±13.9 | 38.8±17.1 | 0.484b |
Course of disease | 2.51±2.63 | 2.40±2.37 | 0.903b |
Clinical type | 0.001c* | ||
Mild# | 6(8.7%) | 5(50.0%) | |
Moderate# | 56(81.2%) | 5(50.0%) | |
Severe# | 7(10.1%) | 0(0.0%) | |
Re-detectable of RNA after discharged | 1.00a | ||
Negative# | 63(91.3%) | 9(90.0%) | |
Positive# | 6(8.70%) | 1(10.0%) | |
Hospitalization days | 16.6±6.71 | 12.0±5.85 | 0.043b* |
Days of last RNA negative-conversion | 13.0±6.56 | 10.4±5.93 | 0.237b |
Days of last RNA negative-conversion category | 0.319c | ||
< 7 days# | 9(13.0%) | 1(10.0%) | |
7 days~ 14 days# | 35(50.7%) | 8(80.0%) | |
14 days~ 21 days# | 22(31.9%) | 0(0.0%) | |
> 21 days# | 3(4.4%) | 1(10.0%) | |
WBC count (×109/L) | 5.51±2.50 | 4.95±1.90 | 0.502b |
Lymphocyte count | 1.30±0.87 | 1.37±0.39 | 0.813b |
Lymphocyte rate (%) | 24.4±11.2 | 30.7±11.7 | 0.100b |
Neutrophil count(×109/L) | 3.70±2.27 | 3.15±1.89 | 0.469b |
Neutrophil rate (%) | 65.0±14.8 | 60.2±11.6 | 0.328b |